LRP4 and myasthenia gravis: The molecular immunopathology of MG is due to the presence of circulating autoantibodies that specifically target the acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), or low-density lipoprotein (LDL) receptor-related protein 4 (LRP4).